Published March 25, 2009 | Version v1
Journal article

Crystallization and preliminary X-ray analysis of a rat aldose reductase-like protein (AKR1B14)

  • 1. Medicinal Chemistry and Drug Action, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052 (Australia)
  • 2. Laboratory of Biochemistry, Gifu Pharmaceutical Laboratory, Mitahora-Higashi, Gifu 502-8585 (Japan)

Description

Crystals of AKR1B14 were grown from buffered polyethylene glycol solutions and diffracted to 1.86 Å resolution. Mouse vas deferens protein/aldo-keto reductase 1B7 (AKR1B7) is involved in the detoxification of isocaproaldehyde, a steroidogenesis byproduct, and of 4-hydroxynonenal formed by lipid peroxidation. The rat orthologue of AKR1B7 has recently been named AKR1B14 in the AKR superfamily. Recombinant AKR1B14 was expressed in a bacterial system and purified to homogeneity. The purified protein was crystallized from polyethylene glycol solutions using the hanging-drop vapour-diffusion method and an X-ray diffraction data set was collected to 1.86 Å resolution. The crystals belonged to space group P21, with unit-cell parameters a = 50.66, b = 69.14, c = 72.27 Å, β = 96.4°. This is the first crystallization report of a rodent AKR1B7 orthologue

Availability note (English)

Available from http://dx.doi.org/10.1107/S1744309109009762; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664770

Additional details

Publishing Information

Journal Title
Acta Crystallographica. Section F
Journal Volume
65
Journal Issue
Pt 4
Journal Page Range
p. 395-397
ISSN
1744-3091
CODEN
ACSFCL

Optional Information

Copyright
Copyright (c) International Union of Crystallography 2009
Notes
PMCID: PMC2664770; PMID: 19342790; PUBLISHER-ID: fw5205; OAI: oai:pubmedcentral.nih.gov:2664770